Immunic is trading 5.22% down at $7.50, with no company-specific news for November 5 listed in available market headlines.

  • At the 10:29 a.m. price update, its scheduled progressive MS R&D Day was due to begin at 12:30 p.m. ET.
  • The Nasdaq was down 4.24% and the S&P 500 down 2.62%, while biotech was up 2.05%; sector weakness does not explain the decline.
  • No trading-volume information was provided.